These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
441 related articles for article (PubMed ID: 30227219)
21. Participation of the intestinal microbiota in the mechanism of beneficial effect of treatment with synbiotic Syngut on experimental colitis under stress conditions. Konturek PC; Konturek K; Brzozowski T; Wojcik D; Magierowski M; Targosz A; Krzysiek-Maczka G; Sliwowski Z; Strzalka M; Magierowska K; Szczyrk U; Kwiecien S; Ptak-Belowska A; Neurath M; Dieterich W; Wirtz S; Zopf Y J Physiol Pharmacol; 2020 Jun; 71(3):. PubMed ID: 32991312 [TBL] [Abstract][Full Text] [Related]
22. Bifidobacterium and Lactobacillus improve inflammatory bowel disease in zebrafish of different ages by regulating the intestinal mucosal barrier and microbiota. Ni Y; Zhang Y; Zheng L; Rong N; Yang Y; Gong P; Yang Y; Siwu X; Zhang C; Zhu L; Fu Z Life Sci; 2023 Jul; 324():121699. PubMed ID: 37061125 [TBL] [Abstract][Full Text] [Related]
23. VSL#3 can prevent ulcerative colitis-associated carcinogenesis in mice. Wang CS; Li WB; Wang HY; Ma YM; Zhao XH; Yang H; Qian JM; Li JN World J Gastroenterol; 2018 Oct; 24(37):4254-4262. PubMed ID: 30310258 [TBL] [Abstract][Full Text] [Related]
24. Bifidobacterium longum CCM 7952 Promotes Epithelial Barrier Function and Prevents Acute DSS-Induced Colitis in Strictly Strain-Specific Manner. Srutkova D; Schwarzer M; Hudcovic T; Zakostelska Z; Drab V; Spanova A; Rittich B; Kozakova H; Schabussova I PLoS One; 2015; 10(7):e0134050. PubMed ID: 26218526 [TBL] [Abstract][Full Text] [Related]
25. Probiotic mixture supplementation in the preventive management of trinitrobenzenesulfonic acid-induced inflammation in a murine model. Traina G; Menchetti L; Rappa F; Casagrande-Proietti P; Barbato O; Leonardi L; Carini F; Piro F; Brecchia G J Biol Regul Homeost Agents; 2016; 30(3):895-901. PubMed ID: 27655518 [TBL] [Abstract][Full Text] [Related]
26. Active hexose-correlated compound and Bifidobacterium longum BB536 exert symbiotic effects in experimental colitis. Ocón B; Anzola A; Ortega-González M; Zarzuelo A; Suárez MD; Sánchez de Medina F; Martínez-Augustin O Eur J Nutr; 2013 Mar; 52(2):457-66. PubMed ID: 22941198 [TBL] [Abstract][Full Text] [Related]
27. Faecalibacterium prausnitzii upregulates regulatory T cells and anti-inflammatory cytokines in treating TNBS-induced colitis. Qiu X; Zhang M; Yang X; Hong N; Yu C J Crohns Colitis; 2013 Dec; 7(11):e558-68. PubMed ID: 23643066 [TBL] [Abstract][Full Text] [Related]
28. Anti-inflammatory potential of the probiotic dietary supplement Lactibiane Tolérance: in vitro and in vivo considerations. Drouault-Holowacz S; Foligné B; Dennin V; Goudercourt D; Terpend K; Burckel A; Pot B Clin Nutr; 2006 Dec; 25(6):994-1003. PubMed ID: 16698150 [TBL] [Abstract][Full Text] [Related]
29. Enteric Delivery of Regenerating Family Member 3 alpha Alters the Intestinal Microbiota and Controls Inflammation in Mice With Colitis. Darnaud M; Dos Santos A; Gonzalez P; Augui S; Lacoste C; Desterke C; De Hertogh G; Valentino E; Braun E; Zheng J; Boisgard R; Neut C; Dubuquoy L; Chiappini F; Samuel D; Lepage P; Guerrieri F; Doré J; Bréchot C; Moniaux N; Faivre J Gastroenterology; 2018 Mar; 154(4):1009-1023.e14. PubMed ID: 29133078 [TBL] [Abstract][Full Text] [Related]
30. Inflammation-induced Occludin Downregulation Limits Epithelial Apoptosis by Suppressing Caspase-3 Expression. Kuo WT; Shen L; Zuo L; Shashikanth N; Ong MLDM; Wu L; Zha J; Edelblum KL; Wang Y; Wang Y; Nilsen SP; Turner JR Gastroenterology; 2019 Nov; 157(5):1323-1337. PubMed ID: 31401143 [TBL] [Abstract][Full Text] [Related]
31. Cui QY; Tian XY; Liang X; Zhang Z; Wang R; Zhou Y; Yi HX; Gong PM; Lin K; Liu TJ; Zhang LW Food Funct; 2022 May; 13(9):5115-5123. PubMed ID: 35416187 [TBL] [Abstract][Full Text] [Related]
32. Bifidobacterium infantis attenuates colitis by regulating T cell subset responses. Zuo L; Yuan KT; Yu L; Meng QH; Chung PC; Yang DH World J Gastroenterol; 2014 Dec; 20(48):18316-29. PubMed ID: 25561798 [TBL] [Abstract][Full Text] [Related]
33. In Vitro Characterization of Gut Microbiota-Derived Commensal Strains: Selection of Cuffaro B; Assohoun ALW; Boutillier D; Súkeníková L; Desramaut J; Boudebbouze S; Salomé-Desnoulez S; Hrdý J; Waligora-Dupriet AJ; Maguin E; Grangette C Cells; 2020 Sep; 9(9):. PubMed ID: 32947881 [TBL] [Abstract][Full Text] [Related]
34. Probiotic mixtures with aerobic constituent promoted the recovery of multi-barriers in DSS-induced chronic colitis. Chen Y; Zhang L; Hong G; Huang C; Qian W; Bai T; Song J; Song Y; Hou X Life Sci; 2020 Jan; 240():117089. PubMed ID: 31759038 [TBL] [Abstract][Full Text] [Related]
35. Partially hydrolysed guar gum ameliorates murine intestinal inflammation in association with modulating luminal microbiota and SCFA. Takagi T; Naito Y; Higashimura Y; Ushiroda C; Mizushima K; Ohashi Y; Yasukawa Z; Ozeki M; Tokunaga M; Okubo T; Katada K; Kamada K; Uchiyama K; Handa O; Itoh Y; Yoshikawa T Br J Nutr; 2016 Oct; 116(7):1199-1205. PubMed ID: 27604176 [TBL] [Abstract][Full Text] [Related]
36. The Epithelial Barrier Model Shows That the Properties of VSL#3 Depend from Where it is Manufactured. Palumbo P; Lombardi F; Cifone MG; Cinque B Endocr Metab Immune Disord Drug Targets; 2019; 19(2):199-206. PubMed ID: 30360752 [TBL] [Abstract][Full Text] [Related]
37. Preventative effects of a probiotic, Lactobacillus salivarius ssp. salivarius, in the TNBS model of rat colitis. Peran L; Camuesco D; Comalada M; Nieto A; Concha A; Diaz-Ropero MP; Olivares M; Xaus J; Zarzuelo A; Galvez J World J Gastroenterol; 2005 Sep; 11(33):5185-92. PubMed ID: 16127750 [TBL] [Abstract][Full Text] [Related]
38. VSL#3 Probiotic Stimulates T-cell Protein Tyrosine Phosphatase-mediated Recovery of IFN-γ-induced Intestinal Epithelial Barrier Defects. Krishnan M; Penrose HM; Shah NN; Marchelletta RR; McCole DF Inflamm Bowel Dis; 2016 Dec; 22(12):2811-2823. PubMed ID: 27824650 [TBL] [Abstract][Full Text] [Related]
39. Posttranslational inhibition of proinflammatory chemokine secretion in intestinal epithelial cells: implications for specific IBD indications. Hörmannsperger G; Clavel T; Hoffmann M; Reiff C; Kelly D; Loh G; Blaut M; Hölzlwimmer G; Haller D J Clin Gastroenterol; 2010 Sep; 44 Suppl 1():S10-5. PubMed ID: 20562631 [TBL] [Abstract][Full Text] [Related]
40. Schistosoma japonicum ova maintains epithelial barrier function during experimental colitis. Xia CM; Zhao Y; Jiang L; Jiang J; Zhang SC World J Gastroenterol; 2011 Nov; 17(43):4810-6. PubMed ID: 22147983 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]